MedCity Influencers

Beyond One-Size-Fits-All: Women, Substance Use, and the Need for Gender-Responsive Care

While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: gender meaningfully influences how substance use develops, how it is experienced, and what supports effective treatment.

Substance use disorder (SUD) among women has become a growing public health concern, reflecting a marked shift over the past two decades. While men historically had significantly higher rates, this gender gap is narrowing as prevalence among women rises. Recent data indicate that 7.4% of adult women in the U.S. meet criteria for SUD annually, with rates reaching 10.2% among young women aged 18–25.  High-risk drinking increased by 58% among women compared to just 16% among men, and Alcohol Use Disorder rose by 84%, dwarfing the 34% increase seen in men. While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: gender meaningfully influences how substance use develops, how it is experienced, and what supports effective treatment. For women, these differences are not peripheral. They are central to engagement, retention, and outcomes. 

Understanding how SUD develops in women

SUDs in women often follow distinct developmental pathways shaped by biological, psychological, and social factors. Biologically, women tend to experience a telescoping effect: a more rapid progression from initial substance use to dependence compared to men. Hormonal influences, particularly estrogen, may heighten sensitivity to reward and craving, accelerating this trajectory. Additionally, women often experience health consequences, such as liver disease, more quickly and at lower levels of use. 

presented by

Psychological factors can also affect the way SUD develops. Women with SUD have higher rates of co-occurring mental health conditions, particularly depression, anxiety, and post-traumatic stress disorder (PTSD). Many report histories of interpersonal violence, including sexual abuse or intimate partner violence, which can shape both the onset and continuation of substance use. For women, substances may be seen as a way of coping, managing overwhelming emotions, numbing distress, or regaining a sense of control.

Social context further complicates risk. Women are more likely to take on caregiving roles, whether as mothers, daughters, or partners, which can both motivate recovery and create barriers for accessing care. Women with SUD frequently face harsher societal judgment, which can delay help-seeking and intensify internalized shame. Relationship dynamics, especially with partners who also use substances, can reinforce use and challenge recovery.

Barriers that keep women from treatment

Despite clear need, women often encounter significant obstacles to entering and staying in treatment. Self-stigma, shame, and guilt remain pervasive internal barriers often compounded by low perceived self-efficacy and limited social support. Some fear judgment, not just from society, but from healthcare systems that may not feel safe or understanding. Fear of losing custody of children can deter women from disclosing substance use or seeking help altogether.

Systemically, most treatment models were designed around male populations and may not fully address women’s needs. Trauma is often under-assessed or insufficiently recognized during care. Similarly, research on medications for SUD has historically underrepresented women, resulting in gaps in our understanding of how pharmacological treatments may differ by sex. When women do not see their experiences reflected or understood in treatment, they are less likely to remain engaged.

What women need in treatment

One of the most consistent findings across research and clinical practice is the importance of relational context in women’s recovery. Women often place a high value on therapeutic relationships characterized by trust, compassion, and emotional safety. Because women are statistically more likely to enter treatment with histories of interpersonal trauma, the environment must function as a holding space that prioritizes trauma-informed physical and social cues. This connection between trauma exposure and relational safety helps explain why engagement in treatment is often less about “compliance” and more about perceived emotional safety within the care setting. In this context, treatment environments perceived as judgmental or impersonal can quickly lead to disengagement. Women frequently benefit from treatment settings that emphasize psychological safety, a sense of belonging, and collaborative, compassionate care. This includes everything from the intentional design of a calming physical environment to the integration of holistic supports that recognize the complexities of caregiving roles and social expectations. Across these elements, providers’ compassionate tone and attuned therapeutic approach can significantly influence engagement and treatment outcomes.

An evidence-based gender-responsive approach

Gender-responsive treatment is not about creating entirely separate systems for women. It is about adapting evidence-based practices, such as Female-Specific Cognitive Behavioral Therapy (FS-CBT), to better align with women’s needs. Women-specific programming is another important adaptation. Single-gender group therapy provides a space where women often feel safer to discuss sensitive topics without fear of judgment. While mixed-gender groups may work well for some, offering women-only options expands accessibility and comfort.

Family-focused interventions are also particularly important. Given the centrality of relationships in many women’s lives, including family systems (when safe and appropriate) can strengthen recovery. This might include family therapy, parenting support, or services that address the needs of children alongside the patient. 

Holistic, integrated models further enhance treatment effectiveness. Services that address women’s physical health, mental health, social stability, and even spiritual well-being create a more comprehensive pathway to recovery. For women managing multiple roles and stressors, fragmented care is often insufficient.

Recovery trajectories and what supports success

When treatment aligns with women’s needs, their outcomes improve. Retention and completion rates increase when women feel understood, supported, and safe. Key factors that can enhance treatment engagement include flexible scheduling, access to childcare, trauma-informed environments, and strong therapeutic relationships. These structural supports are often just as influential as clinical interventions in determining whether women remain engaged in care long enough to benefit from treatment.

For women, recovery is often shaped by relational and emotional stability. Social support, whether from family, peers, or recovery communities, serves as a powerful protective factor. At the same time, women face elevated relapse risk when their co-occurring mental health conditions are not effectively addressed. It is important to recognize that recovery for women may involve rebuilding multiple domains simultaneously: mental health, relationships, and recovery identity. Treatment that acknowledges and supports this complexity is more likely to succeed.

Implications for treatment providers

SUD treatment has evolved significantly over the past decades, but one-size-fits-all approaches continue to fall short – especially for women. Precise, effective care requires recognizing and responding to gender differences. At the practice level, this begins with assessment. Providers should routinely screen for trauma, co-occurring disorders, and social determinants that may uniquely affect women. Treatment planning should be individualized, with explicit attention to relational needs and environmental context. 

At the organizational level, expanding access to women-centered services is critical. This includes not only specialized programming, but also consideration for other needs such as childcare, flexible scheduling, and transportation. When treatment reflects the realities of women’s lives (their biology, their experiences, and their social contexts), it becomes more accessible, more engaging, and more effective.

Photo: Maria Korneeva, Getty Images

Jami L. Barney, MBA, is the Research Manager at Ashley Addiction Treatment. She has over ten years of experience in addiction treatment, clinical research, healthcare data analytics, and outcomes research. Her work focuses on translating real-world clinical data into meaningful improvements in patient care and advancing evidence-based practices for substance use disorder treatment. Barney has authored multiple peer-reviewed publications, including research on gender disparities in addiction and recovery, and is an invited speaker at conferences on treatment outcomes, digital health technologies, and innovations in addiction research.

Wendy Insalaco, PhD, LCADC, LCPC, is the Senior Director of Clinical Quality Outcomes and Model of Care at Ashley Addiction Treatment. A licensed clinical alcohol and drug counselor and licensed clinical professional counselor, she has more than three decades of experience in substance use disorder treatment and behavioral health leadership. Dr. Insalaco's work focuses on advancing evidence-based addiction treatment through outcomes research and innovative models of care. She regularly presents at national conferences and delivers professional training on topics including best practice in gender-specific treatment for women. Dr. Insalaco is the author of peer-reviewed research publications, book chapters, and professional articles aimed at improving addiction treatment outcomes.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.